These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29444898)

  • 1. Significant prevalence of
    Vitellius G; Trabado S; Hoeffel C; Bouligand J; Bennet A; Castinetti F; Decoudier B; Guiochon-Mantel A; Lombes M; Delemer B;
    Eur J Endocrinol; 2018 Apr; 178(4):411-423. PubMed ID: 29444898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess.
    Bouligand J; Delemer B; Hecart AC; Meduri G; Viengchareun S; Amazit L; Trabado S; Fève B; Guiochon-Mantel A; Young J; Lombès M
    PLoS One; 2010 Oct; 5(10):e13563. PubMed ID: 21042587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of Glucocorticoid Signaling.
    Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
    Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance.
    Vitellius G; Fagart J; Delemer B; Amazit L; Ramos N; Bouligand J; Le Billan F; Castinetti F; Guiochon-Mantel A; Trabado S; Lombès M
    Hum Mutat; 2016 Aug; 37(8):794-803. PubMed ID: 27120390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral adrenal hyperplasia and NR3C1 mutations causing glucocorticoid resistance: Is there an association?
    Nicolaides NC; Chrousos GP
    Eur J Endocrinol; 2018 Oct; 179(5):C1-C4. PubMed ID: 30006372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1.
    Donner KM; Hiltunen TP; Jänne OA; Sane T; Kontula K
    Eur J Endocrinol; 2013 Jan; 168(1):K9-K18. PubMed ID: 23076843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overrepresentation of the N363S variant of the glucocorticoid receptor gene in patients with bilateral adrenal incidentalomas.
    Majnik J; Patocs A; Balogh K; Toth M; Gergics P; Szappanos A; Mondok A; Borgulya G; Panczel P; Prohaszka Z; Racz K
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2796-9. PubMed ID: 16636127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GENETICS IN ENDOCRINOLOGY: Glucocorticoid resistance syndrome.
    Vitellius G; Lombes M
    Eur J Endocrinol; 2020 Feb; 182(2):R15-R27. PubMed ID: 31995340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?
    Emms H; Tsirou I; Cranston T; Tsagarakis S; Grossman AB
    Endocrine; 2016 Sep; 53(3):801-8. PubMed ID: 27306888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of glucocorticoid receptor polymorphism with metabolic outcomes in menopausal women with adrenal incidentalomas.
    Ognjanović S; Antić J; Pekmezović T; Popović B; Isailović T; Antić IB; Bogavac T; Kovačević VE; Ilić D; Opalić M; Macut D
    Maturitas; 2021 Sep; 151():15-21. PubMed ID: 34446274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Clinical Outcome of CYP21A2 Gene Mutations in Patients with Nonfunctional Adrenal Incidentalomas.
    Kiedrowicz B; Binczak-Kuleta A; Lubikowski J; Koziolek M; Andrysiak-Mamos E; Ostanek-Panka M; Ciechanowicz A; Syrenicz A
    Horm Metab Res; 2015 Aug; 47(9):662-7. PubMed ID: 25970792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glucocorticoid receptor polymorphism in adrenal incidentalomas.
    Morelli V; Donadio F; Eller-Vainicher C; Cirello V; Olgiati L; Savoca C; Cairoli E; Salcuni AS; Beck-Peccoz P; Chiodini I
    Eur J Clin Invest; 2010 Sep; 40(9):803-11. PubMed ID: 20584071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor and molecular chaperones in the pathogenesis of adrenal incidentalomas: potential role of reduced sensitivity to glucocorticoids.
    Damjanovic SS; Antic JA; Ilic BB; Cokic BB; Ivovic M; Ognjanovic SI; Isailovic TV; Popovic BM; Bozic IB; Tatic S; Matic G; Todorovic VN; Paunovic I
    Mol Med; 2013 Jan; 18(1):1456-65. PubMed ID: 23196783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical impact of BCL1 polymorphic genotype of the glucocorticoid receptor gene in patients with adrenal incidentalomas.
    Tzanela M; Mantzou E; Saltiki K; Tampourlou M; Kalogeris N; Hadjidakis D; Tsagarakis S; Alevizaki M
    J Endocrinol Invest; 2012 Apr; 35(4):395-400. PubMed ID: 21738001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effect of BclI GR gene polymorphisms on the obesity phenotype in Brazilian patients with Cushing's disease.
    Moreira RP; Bachega TA; Machado MC; Mendonca BB; Bronstein MD; Villares Fragoso MC
    Clinics (Sao Paulo); 2013 May; 68(5):579-85. PubMed ID: 23778418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased deoxyribonucleic acid binding of glucocorticoid-receptor complex in cultured skin fibroblasts from a patient with the glucocorticoid resistance syndrome.
    Nawata H; Sekiya K; Higuchi K; Kato K; Ibayashi H
    J Clin Endocrinol Metab; 1987 Aug; 65(2):219-26. PubMed ID: 3597702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.